Australia's most trusted
source of pharma news
Friday, 31 July 2026
Posted 31 July 2026 AM
As industry undergoes sweeping changes, departures continue with a number of high-profile exits.
AstraZeneca's long time Oncology Buiness Unit Director Heather Cahill is finishing up her time at the company this week.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.